Skip to main content

Advertisement

ADVERTISEMENT

Aortic Interventions News

thoracic endovascular aortic repair
06/28/2024
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible, off-the-shelf single-branch thoracic endoprosthesis for zone 2 treatment. FLAGSTAFF, AZ (June 27, 2024) — W. L. Gore & Associates (Gore) today announced the first commercial use of the GORE® TAG® Thoracic Branch...
The first flexible,...
06/28/2024
Vascular Disease Management
AAA Endoprosthesis
05/01/2024

Gore Media Update

Gore Media Update
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30, 2024) — W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE® EXCLUDER® Conformable AAA Endoprosthesis, now indicated for patients with aortic neck angulation ≤ 90° and a...
FLAGSTAFF, Ariz. (April 30,...
05/01/2024
Vascular Disease Management
News
02/01/2024
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment. PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
MDR CE mark approval signifies the first off-theshelf single-branch thoracic endoprosthesis for patients requiring zone 2 treatment. PUTZBRUNN, GERMANY (February 1, 2024) — W. L. Gore & Associates, Inc. (Gore) today announced the first...
MDR CE mark approval signifies...
02/01/2024
Vascular Disease Management

Advertisement

News
01/31/2024
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction  on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts. FLAGSTAFF, Ariz....
With improvements to the stent graft delivery system enabling a 1 Fr profile reduction  on the majority of sizes, the device now offers the most 6 Fr compatible configurations among balloon expandable stent grafts. FLAGSTAFF, Ariz....
With improvements to the stent...
01/31/2024
Vascular Disease Management
News
01/25/2024
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis approval brings the first branched, all-in-one solution for patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms in patients...
The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis approval brings the first branched, all-in-one solution for patients with thoracoabdominal aortic aneurysms and high-surgical risk patients with pararenal aortic aneurysms in patients...
The GORE® EXCLUDER®...
01/25/2024
Vascular Disease Management
News
01/18/2024
Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm TEMPE, Ariz., January 18,...
Trial to randomize 400 subjects at multiple sites, primarily in the U.S., to evaluate safety and efficacy of the investigational Nectero EAST System for treatment of infrarenal AAA, maximum diameter 3.5-5.0cm TEMPE, Ariz., January 18,...
Trial to randomize 400 subjects...
01/18/2024
Vascular Disease Management

Advertisement

News
12/20/2023
CAUTION: Investigational device. Limited by United States law to investigational use. The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of...
CAUTION: Investigational device. Limited by United States law to investigational use. The first patient implant in the ARISE II Pivotal Study evaluation of the GORE® Ascending Stent Graft represents a major milestone in the development of...
CAUTION: Investigational device....
12/20/2023
Vascular Disease Management
News
09/07/2022
HOUMA, LA - Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the latest generation of Medtronic's self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut FX, designed to enhance ease-of-use...
HOUMA, LA - Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the latest generation of Medtronic's self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut FX, designed to enhance ease-of-use...
HOUMA, LA - Cardiovascular...
09/07/2022
Vascular Disease Management
News
01/25/2022
Rosemont, Ill., January 24, 2022 – A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection (aTBAD) suggests most patients with aTBAD have less than 2 cm of proximal healthy...
Rosemont, Ill., January 24, 2022 – A review evaluating the results of thoracic endovascular aortic repair (TEVAR) following acute type B aortic dissection (aTBAD) suggests most patients with aTBAD have less than 2 cm of proximal healthy...
Rosemont, Ill., January 24, 2022...
01/25/2022
Vascular Disease Management

Advertisement

News
10/25/2021
Whether treating a potentially fatal, fast-moving aortic dissection, or long-term, slowly developing issue with the largest blood vessel in the body, specialists at the new Beaumont Aortic Center treat complex aortic disease with the most...
Whether treating a potentially fatal, fast-moving aortic dissection, or long-term, slowly developing issue with the largest blood vessel in the body, specialists at the new Beaumont Aortic Center treat complex aortic disease with the most...
Whether treating a potentially...
10/25/2021
Vascular Disease Management

Advertisement